| pubmed-article:3507151 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0019944 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0007546 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0037473 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0142825 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0234422 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0037540 | lld:lifeskim |
| pubmed-article:3507151 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:3507151 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3507151 | pubmed:dateCreated | 1989-4-13 | lld:pubmed |
| pubmed-article:3507151 | pubmed:abstractText | Sodium penicillin, sodium cefazolin, and sodium citrate were administered to six adult horses on separate occasions, when awake and during anesthesia. The order of administration was randomized and studies were separated by a minimum of 7 days. Arterial blood pressure decreased significantly (less than 0.05) from control 5 minutes after intravenous (IV) sodium penicillin in awake and anesthetized horses. Systolic arterial blood pressure remained significantly (less than 0.05) decreased 10 minutes after IV sodium penicillin in anesthetized horses. Sodium cefazolin and sodium citrate did not significantly affect any of the measured cardiovascular variables. Although the changes in arterial blood pressure were small (8-15 mm Hg), monitoring of arterial blood pressure is advised when sodium penicillin is administered IV to anesthetized horses. | lld:pubmed |
| pubmed-article:3507151 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3507151 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3507151 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3507151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3507151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3507151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3507151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3507151 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3507151 | pubmed:issn | 0161-3499 | lld:pubmed |
| pubmed-article:3507151 | pubmed:author | pubmed-author:RobertsonJ... | lld:pubmed |
| pubmed-article:3507151 | pubmed:author | pubmed-author:MuirW WWW | lld:pubmed |
| pubmed-article:3507151 | pubmed:author | pubmed-author:SethV KVK | lld:pubmed |
| pubmed-article:3507151 | pubmed:author | pubmed-author:HubbellJ AJA | lld:pubmed |
| pubmed-article:3507151 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3507151 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:3507151 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3507151 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3507151 | pubmed:pagination | 245-50 | lld:pubmed |
| pubmed-article:3507151 | pubmed:dateRevised | 2011-4-25 | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:meshHeading | pubmed-meshheading:3507151-... | lld:pubmed |
| pubmed-article:3507151 | pubmed:articleTitle | Cardiovascular effects of intravenous sodium penicillin, sodium cefazolin, and sodium citrate in awake and anesthetized horses. | lld:pubmed |
| pubmed-article:3507151 | pubmed:affiliation | Department of Veterinary Clinical Sciences, Ohio State University, College of Veterinary Medicine, Columbus. | lld:pubmed |
| pubmed-article:3507151 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3507151 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3507151 | lld:pubmed |
